降低THC的Cannabis sativaL.-溶剂如何确定口服大麻素的生物可用性?
Joanna Bartkowiak-Wieczorek1, Edyta Mądry1, Michał Książkiewicz2
1Physiology Department, Poznan University of Medical Sciences, ul. Święcickiego 6, 61-861 Poznań, Poland.
Nutrients
|June 28, 2023
概括
这项研究表明,大麻提取物含有减少四大麻 (THC) 含量的大麻提取物具有更高的大麻 (CBD) 含量. 与Cremophor相比,拉佩烯溶剂提高了CBD和THC的生物可用性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 大麻素科学 大麻素科学
- 药用化学 医学化学
背景情况:
- 大麻 (CBD) 和四大麻 (THC) 的生物可用性影响了它们的治疗效果.
- 理想情况下,医用大麻制剂需要最小的心理THC.
- 目前的医疗制剂通常具有1:1的CBD/THC比率,需要更低的THC选择.
研究的目的:
- 为了评估CBD和THC的生物可用性和稳定性,从具有显著降低THC含量的Cannabis sativa L.提取物中提取.
- 为了比较不同溶剂 (Rapae oleum和Cremophor) 中的CBD和THC的药理学概况.
- 评估低THC大麻提取物在医疗应用中的潜力.
主要方法:
- 通过口服给Wistar老鼠服用含THC减少的Cannabis sativa提取物 (30 mg/kg),使用Rapae oleum和Cremophor作为溶剂.
- 通过液体染色体质谱法量化CBD和THC的全血和大脑度的量化.
- 对不同溶剂的生物可用性和稳定性的比较分析.
主要成果:
- 与THC相比,在两种溶剂的全血和脑组织中都检测到较高的CBD度.
- 拉皮油显示出CBD和THC的总生物可用性优于Cremophor.
- 在体内观察到一些CBD转化为THC,这是医疗用途的关键因素.
结论:
- 含有较少THC的Cannabis sativa提取物表现出有利的药理学特征,含有较高的CBD度.
- 与Cremophor相比,Rapae oleum是一种更有效的溶剂,可以提高CBD和THC的生物可用性.
- 在体内观察到的CBD转化为THC需要对医疗应用进行仔细考虑,但THC减少的提取物显示出显著的前景.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
235
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
235
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
326
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
326
Factors Influencing Bioavailability: First-Pass Elimination
6.5K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.5K
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.6K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.6K
Factors Influencing Drug Absorption: Drug Dissolution
590
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
590
Factors Affecting Dissolution: Particle Size and Effective Surface Area
898
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
898


